Silence Therapeutics PLC
NASDAQ:SLN
Silence Therapeutics PLC
NASDAQ:SLN
Price:
19.78
USD
Market Closed
Market Cap:
$922.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Silence Therapeutics PLC
NASDAQ:SLN
|
UK |
|
Y
|
Yukon Metals Corp
CNSX:YMC
|
CA |
|
Diversified Energy Company PLC
LSE:DEC
|
US |
Intrinsic Value
Not Available for SLN
There is not enough data to reliably calculate the intrinsic value for Silence Therapeutics PLC.
Do our valuations actually work? See backtest results .
Alternatives to SLN
Fundamental Analysis
What Silence Therapeutics Does
Silence Therapeutics PLC is a GB-based company operating in Biotechnology industry. Silence Therapeutics plc is a global clinical-stage biotechnology company engaged in transforming people’s lives by silencing diseases through precision-engineered medicines created with proprietary siRNA (short interfering RNA) technology. The firm leverages its mRNAi GOLD platform to create siRNAs designed to precisely target and silence disease-associated genes in the liver.
- Headquarters
- United Kingdom UK
- Employees
- 88
- IPO date
- Jan 5, 2010
Financials
Efficiency
Earnings Waterfall
Silence Therapeutics PLC
Silence Therapeutics PLC